Page last updated: 2024-11-02

pioglitazone and Respiratory Distress Syndrome

pioglitazone has been researched along with Respiratory Distress Syndrome in 2 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Respiratory Distress Syndrome: A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA.

Research Excerpts

ExcerptRelevanceReference
" We examined the effects of pioglitazone, a synthetic ligand of PPAR-gamma, against lung ischemia-reperfusion injury in rats."7.72Protective effects of preischemic treatment with pioglitazone, a peroxisome proliferator-activated receptor-gamma ligand, on lung ischemia-reperfusion injury in rats. ( Ito, K; Kato, D; Kitamura, N; Naito, Y; Shimada, J; Takagi, T; Toda, S; Yoshikawa, T, 2004)
" We examined the effects of pioglitazone, a synthetic ligand of PPAR-gamma, against lung ischemia-reperfusion injury in rats."3.72Protective effects of preischemic treatment with pioglitazone, a peroxisome proliferator-activated receptor-gamma ligand, on lung ischemia-reperfusion injury in rats. ( Ito, K; Kato, D; Kitamura, N; Naito, Y; Shimada, J; Takagi, T; Toda, S; Yoshikawa, T, 2004)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Stancioiu, F1
Papadakis, GZ1
Kteniadakis, S1
Izotov, BN1
Coleman, MD1
Spandidos, DA1
Tsatsakis, A1
Ito, K1
Shimada, J1
Kato, D1
Toda, S1
Takagi, T1
Naito, Y1
Yoshikawa, T1
Kitamura, N1

Reviews

1 review available for pioglitazone and Respiratory Distress Syndrome

ArticleYear
A dissection of SARS‑CoV2 with clinical implications (Review).
    International journal of molecular medicine, 2020, Volume: 46, Issue:2

    Topics: Amiodarone; Animals; COVID-19; Curcumin; Humans; Pioglitazone; Respiratory Distress Syndrome; SARS-C

2020

Other Studies

1 other study available for pioglitazone and Respiratory Distress Syndrome

ArticleYear
Protective effects of preischemic treatment with pioglitazone, a peroxisome proliferator-activated receptor-gamma ligand, on lung ischemia-reperfusion injury in rats.
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2004, Volume: 25, Issue:4

    Topics: Animals; Capillary Permeability; Cytokines; Ligands; Lipid Peroxidation; Lung; Male; Microcirculatio

2004